VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Current & emerging biomarkers in multiple myeloma

Noemi Puig, MD, PhD, University Hospital Salamanca, Salamanca, Spain, outlines current and emerging biomarkers used at diagnosis in multiple myeloma, highlighting the potential of circulating tumor plasma cells as a prognostic factor in both smoldering myeloma and multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter